Data / Form D filings / CELL THERAPEUTICS INC
CELL THERAPEUTICS INC: Form D filings
CELL THERAPEUTICS INC, a pharmaceuticals company in Seattle, WA, filed 2 Form D notices with the SEC in 2010. The latest, on August 4, 2010, reports $4.1 million sold of a $4.1 million offering to 1 investor.
Find out what CELL THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 501 ELLIOTT AVE W, STE 400, Seattle, WA, 98119
- Phone
- (206) 270-7100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 891293
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2010 | New notice | $4,060,000 | $4,060,000 | $0 | 1 | Jul 27, 2010 | sec.gov |
| Jun 4, 2010 | New notice | $28,463,000 | $1,848,000 | $26,615,000 | 10 | May 18, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Craig W. Philips | Executive Officer | |
| Louis A. Bianco | Executive Officer | |
| James A. Bianco | Executive Officer, Director | |
| John H. Bauer | Director | |
| Richard L. Love | Director | |
| Jack W. Singer | Executive Officer, Director | |
| Frederick W. Telling | Director | |
| Daniel G. Eramian | Executive Officer | |
| Mary O. Mundinger | Director | |
| Phillip M. Nudelman | Director | |
| Vartan H. Gregorian | Director |
Other pharmaceuticals companies in Washington that filed recently
- Aptevo Therapeutics Inc. $3.5 million · Aug 26, 2026
Every Form D from the week of Aug 2, 2010 · All recent filings in Washington · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CELL THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.